0001658551-20-000001.txt : 20200128
0001658551-20-000001.hdr.sgml : 20200128
20200128165119
ACCESSION NUMBER: 0001658551-20-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200128
DATE AS OF CHANGE: 20200128
EFFECTIVENESS DATE: 20200128
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658551
IRS NUMBER: 464600503
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-356768
FILM NUMBER: 20555126
BUSINESS ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-683-0917
MAIL ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001658551
Amylyx Pharmaceuticals, Inc.
43 THORNDIKE STREET
CAMBRIDGE
MA
MASSACHUSETTS
02141
617-683-0917
DELAWARE
None
None
Corporation
true
Joshua
Cohen
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Executive Officer
Director
Justin
Klee
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Executive Officer
Director
Stephen
Chubb
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Director
George
Milne
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Director
Peter
Finn
c/o Rubin and Rudman LLP
53 State Street
Boston
MA
MASSACHUSETTS
02110
Executive Officer
Walter
Gilbert
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Director
Isaac
Cheng
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Director
Felix
Von Coerper
43 Thorndike Street
Cambridge
MA
MASSACHUSETTS
02141
Director
Pharmaceuticals
Decline to Disclose
- 06b
true
0001658551-19-000003
2019-12-17
false
true
false
10000
20000000
14773328
5226672
false
37
0
0
360000
true
Executive Compensation
false
Amylyx Pharmaceuticals, Inc.
Peter B. Finn
Peter B. Finn
Secretary
2020-01-28